Hematocrit and impact of transfusion in patients receiving extracorporeal life support

Abstract

Introduction: Increasing the hematocrit is considered to increase oxygen delivery to the patient, especially when hypoxic conditions exist and the patient may become more stable. The aim of this study was to evaluate the relationship between hematocrit and hospital mortality via subgroup analyses of trauma and non-trauma patients. Methods: The hospital length of stay (LOS) and LOS in the intensive care unit (ICU) and hospital after extracorporeal life support (ECLS) treatment of 81 patients were analyzed and compared. In-hospital survival until extracorporeal membrane oxygen (ECMO) weaning and hospital discharge were defined as the clinical outcome. Results: Significantly increased mortality, with a relative risk of 1.73 with a 95% confidence interval of 1.134 to 2.639, was identified in the group with an hematocrit greater than 31%. However, no significant differences in relative risk (95% confidence interval) of death for each group were found among groups with an hematocrit less than or equal to 25%, 26-28% and 29-31%. Additionally, no significant relationship between survival and median hematocrit level was observed at a significance level of 0.413 and an Exp (B) of 1.089 at a 95% confidence interval of 0.878 to 1.373 in binary logistic regression analysis; a model was established with a -2 log likelihood of 40.687 for the entire group of patients. Moreover, a significant increase in mortality was observed as the average number of transfusions per day in the hospital increased (significance level 0.024, Exp (B) 4.378, 95% confidence interval for Exp (B) 1.212 to 15.810). Conclusion: Because a variety of factors influence therapy, the indication for transfusion should be re-evaluated and adapted repeatedly on a case-by-case basis. Further studies are needed to demonstrate whether an acceptable outcome from ECLS device therapy can also be achieved with a low hematocrit and a restrictive indication for transfusion.

Keywords

hematocrit hemoglobin transfusion outcome VV ECMO VA ECMO ECLS

Get full access to this article

View all access options for this article.

References

Carson

Carless

PA and

Hebert

PC.

Outcomes using lower vs higher hemoglobin thresholds for red blood cell transfusion. JAMA 2013; 309: 83–84.

Gong

Thompson

Williams

et al . Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 2005; 33: 1191–1198.

Marik

Corwin

HL.

Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008; 36: 2667–2674.

Zilberberg

Carter

Lefebvre

et al . Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study. Crit Care 2007; 11: R63.

Marik

Corwin

HL.

Acute lung injury following blood transfusion: expanding the definition. Crit Care Med 2008; 36: 3080–3084.

Fuller

Gajera

Schorr

et al . Transfusion of packed red blood cells is not associated with improved central venous oxygen saturation or organ function in patients with septic shock. J Emerg Med 2012; 43: 593–598.

Extracorporeal Life Support Organization (ELSO). Guidelines for Adult Respiratory Failure 2017, https://www.elso.org/Portals/0/ELSO%20Guidelines%20For%20Adult%20Respiratory%20Failure%201_4.pdf accessed March 2018

Ang

Teo

Lim

et al . Blood transfusion requirements and independent predictors of increased transfusion requirements among adult patients on extracorporeal membrane oxygenation – a single centre experience. Vox Sang 2009; 96: 34–43.

Schwartz

SM.

Tattered and torn: the life of a RBC on the extracorporeal membrane oxygenation circuit. Crit Care Med 2014; 42: 1314–1315.

10.

Smith

Hardison

Bridges

et al . Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation. Perfusion 2013; 28: 54–60.

11.

Voelker

Busch

Bercker

et al . Restrictive transfusion practice during extracorporeal membrane oxygenation therapy for severe acute respiratory distress syndrome. Artif Organs 2015; 39: 374–378.

12.

Le Gall

Loirat

Alperovitch

et al . A simplified acute physiology score for ICU patients. Crit Care Med 1984; 12: 975–977.

13.

Le Gall

Lemeshow

Saulnier

A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957–2963.

14.

Vazquez

Benito

Rivera

et al . Simplified Acute Physiology Score III: a project for a new multidimensional tool for evaluating intensive care unit performance. Crit Care 2003; 7: 345–346.

15.

Vincent

Moreno

Takala

et al . The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707–710.

16.

Lindholm

Palmer

Frenckner

Long-term ECMO treatment in Jehovah’s Witness patient without transfusions. Perfusion 2012; 27: 332–334.

17.

Croce

Tolley

Claridge

et al . Transfusions result in pulmonary morbidity and death after a moderate degree of injury. J Trauma 2005; 59: 19–23; discussion 23-24.

18.

Patel

Kidane

Klingel

et al . Risks associated with red blood cell transfusion in the trauma population, a meta-analysis. Injury 2014; 45: 1522–1533.

19.

Silverboard

Aisiku

Martin

et al . The role of acute blood transfusion in the development of acute respiratory distress syndrome in patients with severe trauma. J Trauma 2005; 59: 717–723.

20.

Kwasiborski

Kowalczyk

Mrowka

et al . Selected, biochemical markers of hypoxia. Przegl Lek 2012; 69: 115–119.

21.

Farias

Herrera

Carrasco-Pozo

et al . Pharmacological models and approaches for pathophysiological conditions associated with hypoxia and oxidative stress. Pharmacol Ther 2016; 158: 1–23.

22.

Nauta

van Hinsbergh

Koolwijk

Hypoxic signaling during tissue repair and regenerative medicine. Int J Mol Sci 2014; 15: 19791–19815.

23.

Gomez

CR.

Editorial: Tumor hypoxia: impact in tumorigenesis, diagnosis, prognosis, and therapeutics. Front Oncol 2016; 6: 229.

24.

Gazzolo

Abella

Marinoni

et al . New markers of neonatal neurology. J Matern Fetal Neonatal Med 2009; 22: 57–61.